6.400USDMkt Cap: 173.28M USDP/E: —Last update: 2026-05-22
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver suppl…
Industry Peers
Medical Devices152.25BUSDP/E 24.5
85.88BUSDP/E 24.2
53.45BSEKP/E 22.6
53.33BSEKP/E 98.9
52.13BDKKP/E 22.1
38.61BEURP/E 18.3
23.15BSEK—
22.25BEURP/E 23.4
loading…
Indicators:|
Key Statistics
Company
Market Cap173.28M USD
Enterprise Value80.31M USD
Revenue (TTM)351.50M USD
Gross Profit154.26M USD
Net Income (TTM)-22.75M USD
Revenue/Share12.95 USD
Last Price6.400 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees753
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS4568371037
Valuation
P/E (Trailing)—
P/E (Forward)-24.65
PEG—
EV/EBITDA-9.11
EV/Revenue0.23
P/S0.49
P/B0.96
EPS (TTM)-0.91
EPS (Forward)-0.26
52W Range
6.34036% of range6.505
52W High6.505 USD
52W Low6.340 USD
Profitability
Gross Margin44.24%
Oper. Margin-9.89%
EBITDA Margin-2.51%
Profit Margin-6.52%
ROE-11.83%
ROA-7.62%
Growth
Revenue Growth3.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.22M USD
CapEx (TTM)10.38M USD
FCF Margin-0.68%
FCF Yield-1.39%
Net Debt-93.24M USD
Net Debt/EBITDA10.58
Balance Sheet
Debt/Equity0.09
Current Ratio3.10
Quick Ratio2.47
Book Value/Sh6.684 USD
Cash/Share4.069 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)12.67 USD
Target Range12.00 USD – 14.00 USD
# Analysts3
Ownership
Shares Out.27.07M
Float23.85M
Insiders11.90%
Institutions77.76%
Short Interest
Short Ratio3.5d
Short % Float3.91%
Short % Out.3.84%
Shares Short1.05M
Short (prev mo.)1.12M
Technical
SMA 506.593 (-2.9%)
SMA 2007.042 (-9.1%)
Beta1.65
S&P 52W Chg28.31%
Avg Vol (30d)215.94K
Avg Vol (10d)449.44K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—